Recent Quotes
My Watchlist
Indicators
Star 60
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Burning Rock Biotech Ltd ADR (NQ: BNR )

6.780 UNCHANGED
Streaming Delayed Price Updated: 3:41 PM EDT, Jun 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 6.780
Bid (Size) 2.720 (2)
Ask (Size) 8.790 (1)
Prev. Close 6.780
Today's Range 6.780 - 6.780
52wk Range 0.5722 - 8.990
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Burning Rock Regains Compliance with NASDAQ Minimum Bid Price Requirement
From Burning Rock Biotech Limited
Via GlobeNewswire
Week In Review: MediLink And BioNTech Form $1.8 Billion ADC Partnership
Suzhou MediLink partnered with Germany’s BioNTech to use MediLink’s TMALIN antibody-drug conjugate platform. MediLink will receive an upfront payment of $25 million and up to $1.8 billion in... 
Via Talk Markets

Performance

YTD
+599.69%
+599.69%
1 Month
-10.20%
-10.20%
3 Month
+853.45%
+853.45%
6 Month
+737.04%
+737.04%
1 Year
+216.08%
+216.08%

More News

Read More
Bayer and Burning Rock collaborate to increase patient access to precision cancer medicines
From Burning Rock Biotech Limited
Via GlobeNewswire
BNR Stock Earnings: Burning Rock Biotech Reported Results for Q1 2024
Via InvestorPlace
Burning Rock Reports First Quarter 2024 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Publishes 2023 Annual Report on Form 20-F
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces ADS Ratio Change
From Burning Rock Biotech Limited
Via GlobeNewswire
Three AI Stocks That Are Trading At A Discount In April 2024
Via Talk Markets
Topics Artificial Intelligence
Exposures Artificial Intelligence
BNR Stock Earnings: Burning Rock Biotech Reported Results for Q4 2023
Via InvestorPlace
Burning Rock Reports Fourth Quarter and Full Year 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Burning Rock Announces Receipt of Notification from NASDAQ
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces Results of 2023 Annual General Meeting
From Burning Rock Biotech Limited
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Earnings Scheduled For November 30, 2023
Via Benzinga
Burning Rock Reports Third Quarter 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Announces 2023 Annual General Meeting to be Held on December 20, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Schedules Third Quarter of 2023 Earnings Release on November 30, 2023
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock and Boehringer Ingelheim Achieved a Master Service Agreement in Oncology Companion Diagnostics
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Received Breakthrough Device Designation from China’s NMPA for its Multi-Cancer Early Detection Test
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock's minimal residual disease (MRD) product supports advancement in early-stage non-small cell lung cancer treatment, with results published in the Cancer Cell
From Burning Rock Biotech Limited
Via GlobeNewswire
Burning Rock Reports Second Quarter 2023 Financial Results
From Burning Rock Biotech Limited
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.